Progress with optogenetic functional MRI and its translational implications

Future Neurology

Volumn 8, Issue 6, 2013, Pages 691-700

  Weitz, Andrew J ^a   Lee, Jin Hyung ^a,b  

^a Stanford University   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

blood oxygen level dependent; brain mapping; functional MRI; neural networks; optogenetic functional MRI; optogenetics

Indexed keywords

ASTROCYTE; BLOOD FLOW; BOLD SIGNAL; BRAIN NERVE CELL; BRAIN REGION; CELL POPULATION; ELECTROENCEPHALOGRAM; EVOKED CORTICAL RESPONSE; FLOW RATE; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEMODYNAMICS; HUMAN; IMAGE ANALYSIS; MOLECULAR DYNAMICS; NEUROIMAGING; NONHUMAN; OPTOGENETICS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REVIEW; SIGNAL DETECTION;

EID: 84887233663     PISSN: 14796708     EISSN: 17486971     Source Type: Journal    
DOI: 10.2217/fnl.13.42     Document Type: Review

References (81)

1. Alivisatos AP, Chun MY, Church GM, Greenspan RJ, Roukes ML, Yuste R. The brain activity map project and the challenge of functional connectomics. Neuron 74(6), 970-974 (2012).
2. Bohland J W, Wu CZ, Barbas H et al. A proposal for a coordinated effort for the determination of brainwide neuroanatomical connectivity in model organisms at a mesoscopic scale. PLoS Comput. Biol. 5(3), e1000334 (2009).
3. Sporns O. The human connectome: a complex network. Ann. NY Acad. Sci. 1224, 109-125 (2011).
4. Briggman KL, Denk W. Towards neural circuit reconstruction with volume electron microscopy techniques. Curr. Opin. Neurobiol. 16(5), 562-570 (2006). (Pubitemid 44466398)
5. Wilt BA, Burns LD, Ho ETW, Ghosh KK, Mukamel EA, Schnitzer MJ. Advances in light microscopy for neuroscience. Ann. Rev. Neurosci. 32, 435-506 (2009).
6. Stosiek C, Garaschuk O, Holthoff K, Konnerth A. In vivo two-photon calcium imaging of neuronal networks. Proc. Natl Acad. Sci. USA 100(12), 7319-7324 (2003). (Pubitemid 36706436)
7. Chanda B, Blunck R, Faria LC, Schweizer FE, Mody I, Bezanilla F. A hybrid approach to measuring electrical activity in genetically specifed neurons. Nat. Neurosci. 8(11), 1619-1626 (2005). (Pubitemid 41573678)
8. Scanziani M, Hausser M. Electrophysiology in the age of light. Nature 461(7266), 930-939 (2009).
9. Burns SP, Sritharan D, Jouny C et al. A network ana lysis of the dynamics of seizure. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2012, 4684-4687 (2012).
10. Peyron R, Faillenot I, Pomares FB, Le Bars D, Garcia-Larrea L, Laurent B. Mechanical allodynia in neuropathic pain. Where are the brain representations located? A positron emission tomography (PET) study. Eur. J. Pain 17(9), 1327-1337 (2013).
11. Kringelbach ML, Hansen PC, Green AL, Aziz TZ. Using magnetoencephalography to elucidate the principles of deep brain stimulation. MEG: an Introduction to Methods. Oxford University Press, NY, USA, 403-423 (2010).
12. Yeo BTT, Krienen FM, Sepulcre J et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J. Neurophysiol. 106(3), 1125-1165 (2011).
13. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc. Natl Acad. Sci. USA 101(13), 4637-4642 (2004). (Pubitemid 38437463)
14. Huang C, Tang C, Feigin A et al. Changes in network activity with the progression of Parkinson's disease. Brain 130(Pt 7), 1834-1846 (2007). (Pubitemid 47343798)
15. Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, Webb SJ. Autism and abnormal development of brain connectivity. J. Neurosci. 24(42), 9228-9231 (2004). (Pubitemid 39426157)
16. Liao W, Zhang ZQ, Pan ZY et al. Default mode network abnormalities in mesial temporal lobe epilepsy: a study combining fMRI and DTI. Hum. Brain Mapp. 32(6), 883-895 (2011).
17. Menon V. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn. Sci. 15(10), 483-506 (2011).
18. Deisseroth K. Optogenetics. Nat. Methods 8(1), 26-29 (2011).
19. Arenkiel BR, Ehlers MD. Molecular genetics and imaging technologies for circuit-based neuroanatomy. Nature 461(7266), 900-907 (2009).
20. Tye KM, Deisseroth K. Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat. Rev. Neurosci. 13(4), 251-266 (2012).
21. Kravitz AV, Freeze BS, Parker PR et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466(7306), 622-626 (2010).
22. Kim SY, Adhikari A, Lee SY et al. Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature 496(7444), 219-223 (2013).
23. Tye KM, Mirzabekov JJ, Warden MR et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 493(7433), 537-541 (2013).
24. Chaudhury D, Walsh JJ, Friedman AK et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493(7433), 532-536 (2013).
25. Paz JT, Davidson TJ, Frechette ES et al. Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat. Neurosci. 16(1), 64-70 (2013).
26. Krook-Magnuson E, Armstrong C, Oijala M, Soltesz I. On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy. Nat. Commun. 4, 1376 (2013).
27. Stefanik MT, Moussawi K, Kupchik YM et al. Optogenetic inhibition of cocaine seeking in rats. Addict. Biol. 18(1), 50-53 (2013).
28. Ahmari SE, Spellman T, Douglass NL et al. Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science 340(6137), 1234-1239 (2013).
29. Burguiere E, Monteiro P, Feng G, Graybiel AM. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science 340(6137), 1243-1246 (2013).
30. Yizhar O, Fenno LE, Prigge M et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 477(7363), 171-178 (2011).
31. Famm K, Litt B, Tracey KJ, Boyden ES, Slaoui M. Drug discovery: a jump-start for electroceuticals. Nature 496(7444), 159-161 (2013).
32. Lee JH, Durand R, Gradinaru V et al. Global and local fMRI signals driven by neurons defned optogenetically by type and wiring. Nature 465(7299), 788-792 (2010).
33. Lee JH. Informing brain connectivity with optogenetic functional magnetic resonance imaging. Neuroimage 62(4), 2244-2249 (2012).
34. Gerits A, Farivar R, Rosen BR, Wald LL, Boyden ES, Vanduffel W. Optogenetically induced behavioral and functional network changes in primates. Curr. Biol. 22(18), 1722-1726 (2012).
35. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci. 8(9), 1263-1268 (2005). (Pubitemid 43348147)
36. Ranck JB. Which elements are excited in electrical stimulation of mammalian central nervous system: a review. Brain Res. 98(3), 417-440 (1975).
37. Diester I, Kaufman MT, Mogri M et al. An optogenetic toolbox designed for primates. Nat. Neurosci. 14(3), 387-397 (2011).
38. Gerits A, Vanduffel W. Optogenetics in primates: a shining future? Trends Genet. 29(7), 403-411 (2013).
39. Zhang F, Wang LP, Boyden ES, Deisseroth K. Channelrhodopsin-2 and optical control of excitable cells. Nat. Methods 3(10), 785-792 (2006). (Pubitemid 44445824)
40. Han X, Boyden ES. Multiple-color optical activation, silencing, and desynchronization of neural activity, with single-spike temporal resolution. PLoS ONE 2(3), e299 (2007).
41. Mattis J, Tye KM, Ferenczi EA et al. Principles for applying optogenetic tools derived from direct comparative ana lysis of microbial opsins. Nat. Methods 9(2), 159-172 (2012).
42. Gunaydin LA, Yizhar O, Berndt A, Sohal VS, Deisseroth K, Hegemann P. Ultrafast optogenetic control. Nat. Neurosci. 13(3), 387-392 (2010).
43. Berndt A, Yizhar O, Gunaydin LA, Hegemann P, Deisseroth K. Bi-stable neural state switches. Nat. Neurosci. 12(2), 229-234 (2009).
44. Zhang F, Prigge M, Beyriere F et al. Red-shifted optogenetic excitation: a tool for fast neural control derived from Volvox carteri. Nat. Neurosci. 11(6), 631-633 (2008). (Pubitemid 351748117)
45. Busskamp V, Picaud S, Sahel JA, Roska B. Optogenetic therapy for retinitis pigmentosa. Gene Ther. 19(2), 169-175 (2012).
46. Chow BY, Boyden ES. Optogenetics and translational medicine. Sci. Transl. Med. 5(177), 177ps5 (2013).
47. Williams JC, Denison T. From optogenetic technologies to neuromodulation therapies. Sci. Transl. Med. 5(177), 177ps 6 (2013).
48. Logothetis NK. Bold claims for optogenetics. Nature 468(7323), E3-E4; discussion E4-E5 (2010).
49. Han X, Qian X, Bernstein JG et al. Millisecond-timescale optical control of neural dynamics in the nonhuman primate brain. Neuron 62(2), 191-198 (2009).
50. Desai M, Kahn I, Knoblich U et al. Mapping brain networks in awake mice using combined optical neural control and fMRI. J. Neurophysiol. 105(3), 1393-1405 (2011).
51. Kahn I, Desai M, Knoblich U et al. Characterization of the functional MRI response temporal linearity via optical control of neocortical pyramidal neurons. J. Neurosci. 31(42), 15086-15091 (2011).
52. Domingos AI, Vaynshteyn J, Voss HU et al. Leptin regulates the reward value of nutrient. Nat. Neurosci. 14 (12), 1562-1568 (2011).
53. Abe Y, Sekino M, Terazono Y et al. Opto-fMRI ana lysis for exploring the neuronal connectivity of the hippocampal formation in rats. Neurosci. Res. 74(3-4), 248-255 (2012).
54. Fenno L, Yizhar O, Deisseroth K. The development and application of optogenetics. Ann. Rev. Neurosci. 34, 389-412 (2011).
55. Jazayeri M, Lindbloom-Brown Z, Horwitz GD. Saccadic eye movements evoked by optogenetic activation of primate V1. Nat. Neurosci. 15(10), 1368-1370 (2012).
56. Cavanaugh J, Monosov IE, Mcalonan K et al. Optogenetic inactivation modifes monkey visuomotor behavior. Neuron 76(5), 901-907 (2012).
57. Bittner T, Fuhrmann M, Burgold S et al. Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PLoS ONE 5(11), e15477 (2010).
58. Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 8(3), 280-291 (2009).
59. Hutsler JJ, Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 1309, 83-94 (2010).
60. Fang Z, Lee JH. High-throughput optogenetic functional magnetic resonance imaging with parallel computations. J. Neurosci. Methods 218(2), 184-195 (2013).
61. Le N, Nyugen T, Yu X, Fang Z, Lee J. Compressed sensing enabled ultra-high resolution optogenetic functional magnetic resonance imaging (ofMRI). Proc. Intl Soc. Mag. Reson. Med. 20, 2051 (2012).
62. Ohliger MA, Sodickson DK. An introduction to coil array design for parallel MRI. NMR Biomed. 19(3), 300-315 (2006). (Pubitemid 43811104)
63. Ekstrom LB, Roelfsema PR, Arsenault JT, Bonmassar G, Vanduffel W. Bottom-up dependent gating of frontal signals in early visual cortex. Science 321(5887), 414-417 (2008). (Pubitemid 352029979)
64. Janssens T, Keil B, Farivar R et al. An implanted 8-channel array coil for high-resolution macaque MRI at 3T. Neuroimage 62 (3), 1529-1536 (2012).
65. Ridha BH, Barnes J, Bartlett JW et al. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol. 5(10), 828-834 (2006). (Pubitemid 44715810)
66. Paulsen JS, Zimbelman JL, Hinton SC et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. AJNR Am. J. Neuroradiol. 25(10), 1715-1721 (2004). (Pubitemid 44123696)
67. Lee JH. Tracing activity across the whole brain neural network with optogenetic functional magnetic resonance imaging. Front. Neuroinform. 5, 21 (2011).
68. Mingozzi F, High KA. Therapeutic in vivo gene transfer for genetic disease using A AV: progress and challenges. Nat. Rev. Genet. 12(5), 341-355 (2011).
69. Weerts EM, Fantegrossi WE, Goodwin AK. The value of nonhuman primates in drug abuse research. Exp. Clin. Psychopharmacol. 15(4), 309-327 (2007). (Pubitemid 47445259)
70. Berger B, Gaspar P, Verney C. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci. 14(1), 21-27 (1991).
71. Christie IN, Wells JA, Southern P et al. fMRI response to blue light delivery in the naive brain: implications for combined optogenetic fMRI studies. Neuroimage 66C, 634-641 (2012).
72. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature 412 (6843), 150-157 (2001). (Pubitemid 32674704)
73. Logothetis NK, Pfeuffer J. On the nature of the BOLD fMRI contrast mechanism. Magn. Reson. Imaging 22 (10), 1517-1531 (2004). (Pubitemid 40221946)
74. Logothetis NK. What we can do and what we cannot do with fMRI. Nature 453(7197), 869-878 (2008). (Pubitemid 351832564)
75. Harel N, Lee SP, Nagaoka T, Kim DS, Kim SG. Origin of negative blood oxygenation level-dependent fMRI signals. J. Cereb. Blood Flow Metab. 22(8), 908-917 (2002). (Pubitemid 34831597)
76. Schridde U, Khubchandani M, Motelow JE, Sanganahalli BG, Hyder F, Blumenfeld H. Negative BOLD with large increases in neuronal activity. Cereb. Cortex 18(8), 1814-1827 (2008). (Pubitemid 352019902)
77. Shih YY, Chen CC, Shyu BC et al. A new scenario for negative functional magnetic resonance imaging signals: endogenous neurotransmission. J. Neurosci. 29(10), 3036-3044 (2009).
78. Heeger DJ, Huk AC, Geisler WS, Albrecht DG. Spikes versus BOLD: what does neuroimaging tell us about neuronal activity? Nat. Neurosci. 3(7), 631-633 (2000). (Pubitemid 30437190)
79. Arthurs OJ, Williams EJ, Carpenter TA, Pickard JD, Boniface SJ. Linear coupling between functional magnetic resonance imaging and evoked potential amplitude in human somatosensory cortex. Neuroscience 101(4), 803-806 (2000).
80. Kahn I, Knoblich U, Desai M et al. Optogenetic drive of neocortical pyramidal neurons generates fMRI signals that are correlated with spiking activity. Brain Res. 1511, 33-45 (2013).
81. Scott NA, Murphy TH. Hemodynamic responses evoked by neuronal stimulation via channelrhodopsin-2 can be independent of intracortical glutamatergic synaptic transmission. PLoS ONE 7(1), e29859 (2012).